TY - JOUR
T1 - Changes in IgE-mediated allergy to ubiquitous inhalants after removal from or diminution of exposure to the agent causing occupational asthma
AU - Perfetti, L.
AU - Hébert, J.
AU - Lapalme, Y.
AU - Ghezzo, H.
AU - Gautrin, D.
AU - Malo, J. L.
PY - 1998
Y1 - 1998
N2 - Background: One possibility, among others, for explaining the persistence of asthma symptoms in occupational asthma (OA) after the cessation of exposure to the causal agents may be that subjects become sensitized to ubiquitous inhalants. Objective: The aim of this study was to evaluate the development or increase of IgE-mediated sensitization to ubiquitous allergens, both to high- and low-molecular-weight agents, in 100 subjects with OA after cessation of exposure. Methods: Subjects were evaluated on a first visit, at the time of diagnosis of OA, coinciding with the cessation or diminution of exposure to the causal agent, and on a second visit, 5.8 ± 3.3 years afterwards. At each visit, a history of ocular, nasal and asthmatic symptoms related to exposure to common allergens was obtained together with spirometry and assessment of bronchial responsiveness to methacholine. We analysed total IgE and specific IgE to Dermatophagoides farinae, D. pteronyssinus, birch, ragweed and timothy grass pollens, cat and dog danders, and Alternaria, using enzyme allergosorbent test (EAST) from blood samples taken on each visit. Results: Total IgE levels showed a tendency to diminish. No changes were found in the number of positive EAST (presence of detectable levels of specific IgE) or in the levels of specific IgE. Although significantly more symptoms of rhinoconjunctivitis and asthma in contact with house dust (P <0.05) and pets (P <0.01) were reported on the second visit than on the first, no significant changes in the frequency of symptomatic sensitized subjects were found. Conclusion: Subjects with OA are unlikely to develop IgE-dependent sensitization to common inhalants after removal from exposure to occupational agents.
AB - Background: One possibility, among others, for explaining the persistence of asthma symptoms in occupational asthma (OA) after the cessation of exposure to the causal agents may be that subjects become sensitized to ubiquitous inhalants. Objective: The aim of this study was to evaluate the development or increase of IgE-mediated sensitization to ubiquitous allergens, both to high- and low-molecular-weight agents, in 100 subjects with OA after cessation of exposure. Methods: Subjects were evaluated on a first visit, at the time of diagnosis of OA, coinciding with the cessation or diminution of exposure to the causal agent, and on a second visit, 5.8 ± 3.3 years afterwards. At each visit, a history of ocular, nasal and asthmatic symptoms related to exposure to common allergens was obtained together with spirometry and assessment of bronchial responsiveness to methacholine. We analysed total IgE and specific IgE to Dermatophagoides farinae, D. pteronyssinus, birch, ragweed and timothy grass pollens, cat and dog danders, and Alternaria, using enzyme allergosorbent test (EAST) from blood samples taken on each visit. Results: Total IgE levels showed a tendency to diminish. No changes were found in the number of positive EAST (presence of detectable levels of specific IgE) or in the levels of specific IgE. Although significantly more symptoms of rhinoconjunctivitis and asthma in contact with house dust (P <0.05) and pets (P <0.01) were reported on the second visit than on the first, no significant changes in the frequency of symptomatic sensitized subjects were found. Conclusion: Subjects with OA are unlikely to develop IgE-dependent sensitization to common inhalants after removal from exposure to occupational agents.
KW - Asthma
KW - IgE
KW - Occupational asthma
KW - Occupational diseases
KW - Radioallergosorbent test
UR - http://www.scopus.com/inward/record.url?scp=0031983798&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031983798&partnerID=8YFLogxK
U2 - 10.1046/j.1365-2222.1998.00193.x
DO - 10.1046/j.1365-2222.1998.00193.x
M3 - Article
C2 - 9537782
AN - SCOPUS:0031983798
VL - 28
SP - 66
EP - 73
JO - Clinical and Experimental Allergy
JF - Clinical and Experimental Allergy
SN - 0954-7894
IS - 1
ER -